Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Neuropharmacology. 2014 Apr 3;83:1–8. doi: 10.1016/j.neuropharm.2014.03.013

Table 2.

Convergent Functional Genomics(CFG) is one method of meta-analysis to identify genes which confer susceptibility to complex genetic disorders, including schizophrenia and bipolar disorder. The comparison of chronic LSD induced, differentially expressed genes to the top ranked genes implicated in schizophrenia and bipolar disorder reveals 6 genes common to both lists for schizophrenia, (Bdnf, Drd2, Grin2b, Prkca, Slc1a2, Tnik) and 5 genes in common for bipolar disorder (Bdnf, Gsk3b, Klf12, Ptprt, Syn3). This represents a significant (p=0.006) enrichment of 3.2 fold for schizophrenia genes and a nonsignificant (p=0.19) enrichment of 2.0 fold for bipolar disorder genes (chi-squared, Yates’ corrected, 2×2 contingency table).

Top Ranked Schizophrenia Genes
(CFG score >4.0)(Ayalew et al., 2012)
Top Ranked Bipolar Genes
(CFG score > 6.5)(Patel et al., 2010)
Expect: 4.45% (# of DE genes/Total
genes: 755/16950)
Expect: 4.45% (# of DE genes/Total
genes: 755/16950)
Found: 14.3% (6/42 genes) Found: 8.9% (5/56 genes)
Relative Enrichment: 3.2 Fold Relative Enrichment: 2.0 Fold
Odds Ratio: 3.6 Odds Ratio: 2.1
Significance: p=0.006 Significance: p=0.19